Regulatory and licensing dependence
Cannabis sales require country-specific licenses and compliance with changing laws.
- Scope
- Canada, Israel, and export markets
- Materiality
- high
Cronos Group Inc.
Cronos Group Inc. is a cannabinoid company that develops, brands, manufactures, and distributes cannabis products for adult-use and medical markets. Its portfolio includes Spinach®, PEACE NATURALS®, LIT™, and Lord Jones®, and it operates through licensed production and distribution assets in Canada and Israel.
−2,2 %
42,8 %
−6,4 %
+24,6 %
19.59
18.62
| % | |
|---|---|
| Branded cannabis products | 45% Finished cannabis products sold under Cronos-owned consumer brands across adult-use and medical channels. |
| Canadian adult-use wholesale | 35% Sales to provincial cannabis control authorities and private-sector retailers in Canada. |
| Medical cannabis in Israel | 15% Licensed cultivation, distribution, and pharmacy-based medical cannabis products in Israel. |
| Supply and manufacturing services | 5% Third-party sourcing, contract manufacturing, and processing services supporting product availability. |
Cronos sells primarily to government-controlled cannabis authorities, licensed retailers, and medical cannabis channels...
- Canadian provincial cannabis control authoritiesprimary
Buy wholesale cannabis products for provincial retail distribution and are the largest revenue source.
- Canadian private-sector retailers and distributorssecondary
Purchase cannabis products for resale in provinces where private distribution is permitted.
- Israeli medical cannabis marketprimary
Buys branded medical cannabis products through licensed cultivation, distribution, and pharmacy channels.
- Licensed wholesale and international customerssecondary
Buy dried flower and other cannabis products for export or resale in select international markets.
Cronos is operationally concentrated in Canada and Israel, with principal facilities near Stayner, Ontario and licensed...
- •Canada is the core operating base and largest sales market
- •Ontario is important through Peace Naturals and provincial wholesale demand
- •Israel is a key medical cannabis market with licensed local operations
- •Select international markets are served through exports and supply agreements
- •Regulatory differences by country affect licensing, distribution, and margins
Cronos is focused on building branded cannabis franchises, expanding distribution, and improving supply chain...
01
Brand portfolio expansionmedium-term
Branded products can improve differentiation in a crowded cannabis market.
02
Global distribution networkmedium-term
Broader channel access reduces reliance on any single country or buyer group.
03
Supply chain and capacity expansionshort-term
More reliable production and lower unit costs support margins and service levels.
04
Intellectual property monetizationlong-term
Proprietary product development can create longer-term competitive advantages.
Cronos faces regulatory, supply-chain, and market-structure risk because cannabis remains highly controlled and...
Customer concentration
A few provincial authorities account for a large share of revenue, limiting bargaining power.
- Scope
- Ontario Cannabis Retail Corporation, Alberta Gaming, Liquor and Cannabis Commission
- Materiality
- high
Supply chain and agricultural disruption
Production depends on cultivation, third-party suppliers, and manufacturing partners.
- Scope
- Peace Naturals, Cronos GrowCo, third-party suppliers
- Materiality
- high
Competitive pressure and illicit market
Oversupply and illegal cannabis can reduce pricing and market share in adult-use channels.
- Scope
- Canadian adult-use market
- Materiality
- medium
Impairment of goodwill and intangibles
Brand and reporting-unit values depend on future cash flow assumptions and market conditions.
- Scope
- Lord Jones® and other acquired/intangible assets
- Materiality
- medium
Revenue recognition
Affects quarterly comparability and gross margin presentation
Goodwill and indefinite-lived intangible impairment
Can create large non-cash charges if expectations weaken
Inventory valuation
Can materially affect cost of sales and gross profit
Fair value measurements
Influences impairment testing and acquisition accounting
: 28.4.2026